Can I administer 60 mg intramuscular ketorolac (Toradol) to a 67‑year‑old male with normal renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, do not administer 60 mg IM ketorolac to this 67-year-old patient

Despite having normal renal function, a 67-year-old patient should receive a maximum of 30 mg IM ketorolac, not 60 mg, due to age-related risks and the lack of additional analgesic benefit at higher doses.

Age-Based Dosing Considerations

The 2019 AGS Beers Criteria® identifies NSAIDs, including ketorolac, as medications requiring careful consideration in older adults (≥65 years) 1. While your patient has intact renal function now, age itself is an independent risk factor for NSAID-induced renal toxicity 2, 3, 4.

The Analgesic Ceiling Effect

Ketorolac exhibits a well-established analgesic ceiling effect around 10-15 mg:

  • Low-dose ketorolac (10-20 mg) provides equivalent pain relief to high-dose (≥30 mg) with no clinically meaningful difference in pain scores (mean difference 0.05 mm on 100 mm VAS) 5
  • A 2025 meta-analysis confirmed that lower doses are as effective as standard doses across acute, postoperative, and cancer pain 6
  • The 60 mg dose provides no additional analgesia beyond 30 mg but increases exposure to adverse effects 7

Practical Dosing Algorithm for This Patient

For a 67-year-old with normal renal function:

  1. Initial dose: 15-30 mg IM (not 60 mg)
  2. Monitor renal function if treatment extends beyond single dose
  3. Consider 15 mg if any of these risk factors present:
    • Cardiovascular disease
    • Volume depletion
    • Concurrent ACE inhibitors or ARBs
    • Body weight <50 kg

Safety Profile Comparison

Adverse events increase with dose without added benefit:

  • Total adverse event rate with ketorolac: 74% versus placebo 65% (NNTH 16.7) 8
  • Recent 2025 data shows ketorolac in patients with CKD increases AKI risk significantly (12.7% vs 2.0%, p=0.041) 9
  • While your patient has normal renal function, age 67 places him in a vulnerable category where renal reserve may be diminished

Common Pitfall to Avoid

The 60 mg IM dose is outdated and inappropriate. Practice pattern data shows 45.9% of IM ketorolac doses were given at 60 mg 7, but this reflects prescribing habits that ignore the analgesic ceiling effect. Emergency physicians routinely prescribe above the ceiling dose in 96-97% of cases 7, but evidence does not support this practice.

Use 30 mg IM as your maximum dose for this patient, or preferably start with 15 mg given his age. The lower dose will provide equivalent analgesia with reduced risk of renal, gastrointestinal, and cardiovascular complications that are more common in older adults 1, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.